Loading provider…
Loading provider…
Gastroenterology Physician in New York, NY
NPI: 1144489105Primary Practice Location
MOUNT SINAI HOSPITAL
1184 5th Ave, New York, NY
Primary Employer
Gastroenterology Division of Mount Sinai
icahn.mssm.edu
HQ Phone
Get M.D. Ari's Phone NumberMobile
Get M.D. Ari's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
Albert Einstein College of Medicine of Yeshiva University
Medical School
Until 2008
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 71 | 85 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 67 | 69 |
| 3 | 45380Biopsy of the large bowel using an endoscope (colonoscopy) | 66 | 66 |
| 4 | 45385Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 58 | 59 |
| 5 | 43239Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | 56 | 56 |
Faecal microbiota transplant decreases mortality in severe and fulminant Clostridioides difficile infection in critically ill patients.
Authors: Emily Tixier, Ryan Ungaro
Publication Date: 2019-06-18
Authors: Loren Rabinowitz, Bruce Sands, Stephanie Gold, Ryan Ungaro
Journal: Inflamm Bowel Dis
A Systematic Review of Fecal Microbiota Transplant for the Management of Pouchitis.
Authors: Kayal, Maia, Lambin, Thomas, Pinotti, Rachel, Dubinsky, Marla C, Grinspan, Ari
Journal: Crohns Colitis 360
Publication Date: 2020-05-12
Lead Sponsor: Ari M Grinspan
Intervention / Treatment: DRUG: Placebo, DRUG: Metronidazole, DRUG: Vancomycin, BIOLOGICAL: Fecal Microbiota Transplantation
Lead Sponsor: Microbiome Health Research Institute
Collaborators: Indiana University, Tufts Medical Center, Edward Hospital, Brown University
Intervention / Treatment: DRUG: Fecal Microbiota Preparation
Lead Sponsor: AbbVie
Intervention / Treatment: DRUG: Risankizumab On-Body Injector (OBI), DRUG: Placebo for Risankizumab SC, DRUG: Risankizumab IV, DRUG: Placebo for Risankizumab IV, DRUG: Risankizumab SC